Income statement
USD
Annual
| Metric | 2021 | 2020 | 2019 | 2018 | 2018 |
|---|---|---|---|---|---|
| Revenue | 3M | 1M | 1M | 1M | 0 |
| Gross Profit | 740K | 274K | 263K | 252K | 0 |
| Operating Income | -2M | -27M | -3M | -1M | -1M |
| EBITDA | -3M | -28M | -3M | -1M | -2M |
| Net Income | -4M | -29M | -3M | -1M | -2M |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.003
+0.00% today
1Y Change
+0.00%
Window
Jun 20, 2025 → Jun 1, 2026
Coverage: 237 bars · Jun 20, 2025 → Jun 1, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
PeakBirch Commerce Inc. (PKBFF) is a Healthcare stock with a market cap of $540.00M and listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 20, 2025 → Jun 1, 2026). Baseline metrics include revenue growth of +97.2%, EPS growth of +93.7%, a dividend yield of 0.0%. What stands out right now is revenue +97.2%, EPS +93.7%, free cash flow +28.9% with operating margin -53.1% and ROIC 416.5%. Valuation already assumes a fairly strong business story at price/sales 184.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PKBFF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PKBFF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PKBFF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PKBFF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
-100.0% YoY
FY Net Income
-$2.1M
-87.3% YoY
Free Cash Flow
-$1.5M
-184.0% YoY
Revenue Growth
+97.2%
EPS Growth
+93.7%
Gross Margin
25.1%
Net Margin
-128.3%
Income statement
USD
| Metric | 2021 | 2020 | 2019 | 2018 | 2018 |
|---|---|---|---|---|---|
| Revenue | 3M | 1M | 1M | 1M | 0 |
| Gross Profit | 740K | 274K | 263K | 252K | 0 |
| Operating Income | -2M | -27M | -3M | -1M | -1M |
| EBITDA | -3M | -28M | -3M | -1M | -2M |
| Net Income | -4M | -29M | -3M | -1M | -2M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2021 | 2020 | 2019 | 2018 | 2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | 132K | 232K | 69K | 88K | 684K |
| Total Assets | 850K | 3M | 627K | 3M | 2M |
| Total Liabilities | 2M | 2M | 922K | 562K | 275K |
| Shareholder Equity | -1M | 391K | -295K | 2M | 1M |
| Total Debt | 966K | 1M | 0 | 0 | 0 |
| Net Debt | 835K | 801K | -69K | -88K | -684K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1M
-114.6% YoY
Capital Expenditures
374K
Free Cash Flow
2M
-184.0% YoY
Key ratios
Gross Margin
25.1%
Operating Margin
-53.1%
Net Margin
-128.3%
ROE
796.3%
Debt / Equity
-0.72x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.